Cite
APA Citation
Kagawa, Y., Satake, H., Kato, T., Oba, K., Yasui, H., Nakamura, M., Watanabe, T., Hirata, K., Muro, K., Komatsu, Y., Yoshino, T., Yamazaki, K., Mishima, H., Kotaka, M., Tsuji, A., Kakeji, Y., Oki, E., Nagata, N., & Junichi, S. (n.d.). 107PPhase Ib/II study of biweekly TAS-102 with bevacizumab combination for patients with metastatic colorectal cancer refractory to standard therapies (BiTS study): Phase Ib results. Annals of oncology, 29, . http://access.bl.uk/ark:/81055/vdc_100095322997.0x000037